Search Results - "vaccination"

Regulatory considerations for vaccine development, talk 2 clinical regulatory considerations (part 2 of 2) /

Table of Contents: “…Contents: Biological License Application (BLA) pathways -- Traditional, accelerated approval, "Animal Rule" -- Programs that accelerate the clinical testing (IND) and review (BLA) processes -- Fast track designation -- Breakthrough designation -- Priority review -- The package insert -- Pediatric study requirements -- Adjuvants -- Adaptive trial design from a regulatory perspective -- Developing vaccines for global infectious diseases.…”
Get full text
Series

Usage of vaccines and therapeutics in public health emergencies part 1 of 2 /

Table of Contents: “…Contents: The burden of infectious diseases -- Controlling infection disease and the effect on economy -- The phylogenetic tree of Mononegavirales that includes Ebola virus -- Outbreak of infectious diseases worldwide -- Outbreak responses and tools that can be deployed to better control outbreak -- Ebola virus outbreaks -- Importance of developing novel vaccines and vaccine development process -- Treating "first-responders" with vaccine against Ebola.…”
Get full text
Series

Vaccines as a weapon against antibiotic resistance

Table of Contents: “…Contents: Overview of antibiotic resistance -- WHO Global Action Plan against resistance -- WHO's prioritization of pathogens -- Research discovery against new antibiotics -- Vaccines to combat antibiotic resistance -- Vaccine development against selected WHO prioritized pathogens.…”
Get full text
Series

Usage of vaccines and therapeutics in public health emergencies part 2 of 2 /

Table of Contents: “…Contents: Specific tools including vaccine and therapeutics to control outbreaks -- Improved non-viral DNA-based and viral VSV-based vaccines -- Recent outbreaks in Likati and North Kivu -- New strategies to rapidly develop novel immune therapies and vaccines -- Applications against Ebola virus and others high consequence pathogens -- Recent findings on rapid vaccination regimens and their promising potential.…”
Get full text
Series

Vaccines and the fight against antimicrobial resistance 2

Table of Contents: “…Contents: Vaccines in late-stage development with a potential to reduce AMR -- Vaccines in early-stage development with a potential to reduce AMR -- Global mobilization actions utilizing vaccines against AMR -- The Davos Declaration -- Barriers to maximizing licensed vaccine use in fighting AMR -- Efforts towards better utilization of vaccines against AMR.…”
Get full text
Series

SARS-CoV-2 vaccine development

Table of Contents: “…Contents: Current efforts to develop a vaccine -- Possible strategies for vaccine development -- Possible seasonal variations in virus prevalence -- When could a viable vaccine be expected?.…”
Get full text
Series

The development of SARS-CoV-2 vaccines

Table of Contents: “…Contents: Overview of three SARS-CoV-2 vaccines being developed -- Technologies being used -- Manufacturability -- Current stage of testing -- Next steps.…”
Get full text
Series

mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals

Table of Contents: “…Contents: Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection -- The efficacy of vaccines in previously infected vs previously uninfected individuals -- The efficacy of a single vs double dose -- The potential value of administrating a "booster" that is different from the previous administered vaccine in an individual, AKA "mixing-and-matching".…”
Get full text
Series

Considerations for viral disease eradication lessons learned and future strategies : workshop summary /

Subjects: “…Virus diseases Vaccination Congresses.…”
An electronic book accessible through the World Wide Web; click to view

Retrovirology

Subjects: Open Access

Replication-competent viral vectors

Table of Contents: “…Contents: Virus classifications, infectious diseases, and vaccine approaches -- Vector-based viral vaccines: common barriers and challenges -- Replication-incompetent & competent viral vectors -- Replication-competent vectors in development and in use (VSV-based & YFV-based).…”
Get full text
Series

Tropical Medicine and Health

Subjects: Open Access

WHO Expert Committee on Biological Standardization : sixty-third report. /

Subjects: An electronic book accessible through the World Wide Web; click to view

The vulnerable/empowered woman feminism, postfeminism, and women's health / by Dubriwny, Tasha N., 1976-

Subjects: “…Cervix uteri Cancer Vaccination.…”
An electronic book accessible through the World Wide Web; click to view

Emergence of blood clotting disorders resulting from COVID vaccines inoculations

Table of Contents: “…Contents: The frequency of clotting side-effects in COVID-19 vaccines -- The characteristics of these side-effects and how they compare to other clotting disorders -- What is known regarding the mechanisms underlying these side effects -- What is known regarding populations at greater risk of suffering these side effects.…”
Get full text
Series

The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /

Table of Contents: “…Contents: Mode of action of the Oxford/AstraZeneca RNA vaccine -- Two potential adverse events reported in patients enrolled in the vaccine's phase 3 trial -- Steps undertaken to determine possible causality between the adverse events and the vaccine -- Current status of the trial -- Please note that since the recording of this interview it was determined that "The serious adverse events observed during the trial in these study groups were judged to be unrelated to the study vaccines and occurred at frequencies expected for these conditions in the general population. …”
Get full text
Series

BMC Public Health

Subjects: Open Access

Advances in Nanopathology From Vaccines to Food. by Gatti, Antonietta Morena

Table of Contents: “…The Injection Pathway and Other Entry Channels -- 6.1 Biocompatibility of What Is Introduced in the Body by Injection -- 6.2 Vaccines -- 6.3 Sudden Infant Death Syndrome -- 6.4 Sexually Transmissible Diseases by Particles -- 7. …”
Taylor & Francis
OCLC metadata license agreement

NLR genes infection, inflammation and vaccines /

Get full text
Series

Reverse genetics of RNA viruses applications and perspectives /

Table of Contents: “…Definitions of reverse genetics, +ve, -ve, sense and doubled stranded (DS) RNA viruses / Anne Bridgen -- Coronavirus reverse genetics / Paul Britton -- Hepatitis C and use of reverse genetics in drug design / Natalia Frias Staheli -- Norovirus reverse genetics / Ian Goodfellow -- Rhabdovirus reverse genetics / Klaus Conzelmann -- Modification of measles virus and application to pathogenesis studies / Paul Duprex -- Bunyavirus reverse genetics and application to interaction with host cells / Richard Elliott -- Influenza A virus vaccines / Wendy Barclay -- Bluetongue virus reverse genetics / Mark Boyce -- Reovirus reverse genetics / Rob Hoeben -- Reverse genetics and quasispecies / Marco Vignuzzi -- Summary and perspectives / Anne Bridgen.…”
An electronic book accessible through the World Wide Web; click to view